<DOC>
	<DOCNO>NCT01228630</DOCNO>
	<brief_summary>The loratadine-pseudoephedrine combination proven effective use individual component . This prospective , randomize , double-blind paralel study , patient perennial allergic rhinitis receive one loratadine + pseudoephedrine association drug treatment sign symptoms 4 week .</brief_summary>
	<brief_title>Effectiveness Two Preparations Loratadine + Pseudoephedrine Patients With Perennial Allergic Rhinitis .</brief_title>
	<detailed_description>The effectiveness treatment drug group evaluate global improvement sign ( nasal mucous edema , ocular hyperemia , nasal secretion ) symptom ( itch eye , tear , itch nose , itch palate ) perennial allergic rhinitis , 4 week treatment . Symptoms rhinorrhea , nasal congestion , itch nose , sneeze itch eye consider secondary efficacy endpoint , along questionnaire quality life SF-36 . Safety evaluation data include report adverse event ( include type , frequency , instensity , seriousness , severity action take related investigational product ) report patient , parent legal responsible , ou observe Investigator .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<mesh_term>Fexofenadine</mesh_term>
	<criteria>Comply purpose procedure study sign date IC free . In case minor , document sign dated parent legal guardian ; Have age 12 year , regardless gender , ethnicity social class ; Present clinical status perennial allergic rhinitis mild moderate ; Present clinical status least 12 month evolution ; Submit examination IgE elevation ( 100KU / L ) . Have participate experimental study take experimental drug 12 month precede start study ; Pregnant lactate woman ; Have make use : 1 . Intranasal systemic corticosteroid month inclusion ; 2 . Intranasal cromolyn two week precede inclusion ; 3 . Intranasal systemic decongestant 03 day precede inclusion ; 4 . Intranasal antihistamines systemic 03 day precede survey ; 5 . Loratadine 10 day precede survey . disease anatomical abnormality upper airway could jeopardize analysis data , example , tumor severe septal deviation ; History smoke 03 month precede inclusion ; History alcohol illicit drug ; History liver disease kidney disease ; Electric current asthma gift last year ; Table uncontrolled hypertension ; Patients heart disease use drug cardiovascular system suffer interference drug study , example , Î²blockers ; Patients flulike symptom fever unknown origin , define current within last 07 day ; Clinical diagnosis rhinitis kind allergic perennial ; Be patient sensitivity loratadine , pseudoephedrine sulfate , component formula ; Estimated travel displacement southeast 50 % monitoring .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>rhinitis , loratadine , coat pill</keyword>
</DOC>